Top

Published in:

01-04-2019

Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics: a cross-sectional survey

Published in: Quality of Life Research | Issue 4/2019

Abstract

Purpose

To evaluate the association between medication adherence and quality of life (QoL) of patients with diabetes and/or hypertension attending primary care clinics.

Methods

In this cross-sectional study, patients with at least one long-term condition (hypertension or diabetes mellitus) meeting the eligibility criteria were recruited from five primary care clinics in Saudi Arabia. Arabic version of Morisky Medication Adherence Scale (MMAS-8) and the World Health Organization Quality of Life-BREF (WHOQOL-BREF) tool were used to assess medication adherence and QoL, respectively. Patients’ sociodemographic, medical and medication data were collected using a structured, pilot-tested data collection form.

Results

Three hundred patients with a mean (± SD) age of 56.79 (12.8) years participated in the study. Fifty-eight had hypertension only, 96 had diabetes (Type 1 or 2), and 146 had both hypertension and diabetes. After adjusting for socioeconomic characteristics, multiple linear regression analysis found that adherent patients had significantly higher mean overall perception of QoL and health scores by 14.6 (P = 0.001) and 17.2 (P = 0.001) points, respectively, compared to non-adherent patients. In addition, irrespective of the type of long-term condition, adherence status was found to be an independent predictor of all QoL domains.

Conclusion

There is an association between medication adherence and QoL among patients with diabetes and/or hypertension attending primary care clinics. Medication adherence should be assessed and emphasised during routine clinical consultations in primary care in order to achieve the desired clinical outcomes and overall well-being of patients.

Department of Health Report, National Health services. (2012). Long-term conditions compendium of information (3rd ed.). Accessed January 15, 2017, from https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/216528/dh_134486.pdf.

Adriaanse, M. C., Drewes, H. W., van der Heide, I., Struijs, J. N., & Baan, C. A. (2016). The impact of comorbid chronic conditions on quality of life in type 2 diabetes patients. Quality of Life Research, 25(1), 175–182.CrossRefPubMed

Osterberg, L., & Blaschke, T. (2005). Adherence to medication. The New England Journal of Medicine, 353(5), 487–497. https://doi.org/10.1056/NEJMra050100.CrossRefPubMed

World Health Organization. (2003). Non-communicable diseases and mental health: Progress report 2002–2003. Geneva: World Health Organization. Accessed January 15, 2017, from http://www.who.int/mip/2003/progress/en/nmhmip2003.pdf.

Jackevicius, C. A., Mamdani, M., & Tu, J. V. (2002). Adherence with statin therapy in elderly patients with and without acute coronary syndromes. Journal of the American Medical Association, 288(4), 462–467.CrossRefPubMed

Caro, J. J., Salas, M., Speckman, J. L., Raggio, G., & Jackson, J. D. (1999). Persistence with treatment for hypertension in actual practice. Canadian Medical Association Journal, 160(1), 31–37.PubMed

Haynes, R. B., McDonald, H. P., & Garg, A. X. (2002). Helping patients follow prescribed treatment: Clinical applications. Journal of the American Medical Association, 288(22), 2880–2883.CrossRefPubMed

World Health Organization. (2016). Essential medicines and health products information portal. Adherence to long-term therapies—Evidence for action. Accessed January 17, 2017, from http://apps.who.int/medicinedocs/en/d/Js4883e/6.html.

Marcum, Z. A., Sevick, M. A., & Handler, S. M. (2013). Medication Nonadherence: A diagnosable and treatable medical condition. Journal of the American Medical Association, 309(20), 2105–2106. https://doi.org/10.1001/jama.2013.4638.CrossRefPubMed

10.

World Health Organization. (2016). Country cooperation strategy for WHO and Saudi Arabia. Accessed January 22, 2017, from http://www.who.int/countryfocus/cooperation_strategy/ccs_sau_en.pdf.

11.

Al-Nozha, M. M., Abdullah, M., Arafah, M. R., Khalil, M. Z., Khan, N. B., Al-Mazrou, Y. Y., et al. (2007). Hypertension in Saudi Arabia. Saudi Medical Journal, 28(1), 77–84.PubMed

12.

Alqurashi, K. A., Aljabri, K. S., & Bokhari, S. A. (2011). Prevalence of diabetes mellitus in a Saudi community. Annals of Saudi Medicine, 31(1), 19–23. https://doi.org/10.4103/0256-4947.75773.CrossRefPubMedPubMedCentral

13.

Tourkmani, A. M., Khashan, H. I., Albabtain, M. A., Al Harbi, T. J., Qahatani, H. B., & Bakhiet, A. H. (2012). Medication adherence among patients in a chronic disease clinic. Saudi Medical Journal, 33(12), 1278–1284.PubMed

14.

Al-Sowielem, L. S., & Elzubier, A. G. (1998). Compliance and knowledge of hypertensive patients attending PHC centers in Al-Khobar, Saudi Arabia. Eastern Mediterranean Health Journal, 4(2), 301–307.

15.

Khalil, S. A., & Elzubier, A. G. (1997). Drug compliance among hypertensive patients in Tabuk, Saudi Arabia. Journal of Hypertension, 15(5), 561–565.CrossRefPubMed

16.

Khattab, M. S., Aboifotouh, M. A., Khan, M. Y., Humaidi, M. A., & Al-Kaldi, Y. M. (1999). Compliance and control of diabetes in a family practice setting, Saudi Arabia. Eastern Mediterranean Health Journal, 5(4), 755–765.PubMed

17.

Abdul Jabbar, M., & Al-Shammari, S. A. (1993). Compliance in Saudi epileptic patients: Determinants of compliance in Saudi epileptic patients. Annals of Saudi Medicine, 13(1), 60–63.CrossRefPubMed

18.

Alsolami, F., Hou, X. Y., & Correa-Velez, I. (2012). Factors affecting antihypertensive treatment adherence: A Saudi Arabian perspective. Clinical Medicine and Diagnostics, 2(4), 27–32. https://doi.org/10.5923/j.cmd.20120204.02.CrossRef

19.

AlHewiti, A. (2014). Adherence to long-term therapies and beliefs about medications. International Journal of Family Medicine. https://doi.org/10.1155/2014/479596.PubMedCrossRefPubMedCentral

20.

Gabr, W., & Shams, M. (2015). Adherence to medication among outpatient adolescents with epilepsy. Saudi Pharmaceutical Journal, 23(1), 33–40. https://doi.org/10.1016/j.jsps.2014.05.003.CrossRefPubMed

21.

Khan, A. R., Al-Abdul Lateef, Z. N., Al Aithan, M. A., Bu-Khamseen, M. A., Al Ibrahim, I., & Khan, S. A. (2012). Factors contributing to non-compliance among diabetics attending primary health centers in the Al Hasa district of Saudi Arabia. Journal of Family and Community Medicine, 19(1), 26–32. https://doi.org/10.4103/2230-8229.94008.CrossRefPubMedPubMedCentral

22.

Al-Jahdali, H. H., Al-Zahrani, A. I., Al-Otaibi, S. T., Hassan, I. S., Al-Moamary, M. S., Al-Duhaim, A. S., et al. (2007). Perception of the role of inhaled corticosteroid and factors affecting compliance among asthmatic adult patients. Saudi Medical Journal, 28(4), 569–573.PubMed

23.

Khayyat, S. M., Khayyat, S. M., Hyat Alhazmi, R. S., Mohamed, M. M., & Abdul Hadi, M. (2017). Predictors of medication adherence and blood pressure control among Saudi hypertensive patients attending primary care clinics: A cross-sectional study. PLoS ONE, 12(1), e0171255. https://doi.org/10.1371/journal.pone.0171255.CrossRefPubMedPubMedCentral

24.

Ministry of Health portal. (2012). Kingdom of Saudi Arabia, health statistics annual book. Accessed January 20, 2017, from http://www.moh.gov.sa/en/Ministry/Statistics/book/Documents/1433.pdf.

25.

Morisky, D. E., Ang, A., Krousel-Wood, M., & Ward, H. (2008). Predictive validity of a medication adherence measure for hypertension control. Journal of Clinical Hypertension, 10(5), 348–354.CrossRefPubMed

26.

Krousel-Wood, M. A., Islam, T., Webber, L. S., Re, R. N., Morisky, D. E., & Muntner, P. (2009). New medication adherence scale versus pharmacy fill rates in seniors with hypertension. American Journal of Managed Care, 15(1), 59–66.PubMed

27.

Morisky, D. E., & DiMatteo, M. R. (2011). Improving the measurement of self-reported medication nonadherence: Final response. Journal of Clinical Epidemiology, 64, 258–263.CrossRef

28.

World Health Organization. (1996). Geneva: WHOQOL-BREF introduction, administration, scoring and generic version the assessment. Accessed February 16, 2017, from http://www.who.int/mental_health/media/en/76.pdf.

29.

Bonomi, A. E., Patrick, D. L., Bushnell, D. M., & Martin, M. (2000). Validation of the United States’ version of the World Health Organization Quality of Life (WHOQOL) instrument. Journal of Clinical Epidemiology, 53(1), 1–12.CrossRefPubMed

30.

World Health Organization. (2017). WHOQOL: Measuring quality of life. Accessed September 8, 2017, from http://www.who.int/healthinfo/survey/whoqol-qualityoflife/en/.

31.

Hanus, J. S., Simões, P. W., Amboni, G., Ceretta, L. B., & Tuon, L. G. (2015). Association between quality of life and medication adherence in hypertensive individuals. Acta Paulista de Enfermagem Journal, 28(4), 381–387. https://doi.org/10.1590/1982-0194201500064.CrossRef

32.

Chew, B. H. (2015). Medication adherence on quality of life among adults with type 2 diabetes mellitus: An exploratory analysis on the EDDMQoL study. Quality of Life Research, 24(11), 2723–2731. https://doi.org/10.1007/s11136-015-1006-7.CrossRefPubMed

33.

National Institute for Health and Care Excellence (NICE). (2011). Manchester, UK: Hypertension in adults: Diagnosis and management NICE guidelines [CG127]. [Published August 2011; last updated November 2016]. Accessed April 20, 2018, from https://www.nice.org.uk/guidance/cg127.

34.

National Institute for Health and Care Excellence (NICE). (2015). Manchester, UK: Type 2 diabetes in adults: Management NICE guidelines [NG28]. [Published December 2015; last updated May 2017]. Accessed April 20, 2018, from https://www.nice.org.uk/guidance/ng28.

35.

Lam, C. L., & Lauder, I. J. (2000). The impact of chronic diseases on the health-related quality of life (HRQOL) of Chinese patients in primary care. Family Practice, 17(2), 159–166.CrossRefPubMed

36.

Mollaoğlu, M., Solmaz, G., & Mollaoğlu, M. (2015). Adherence to therapy and quality of life in hypertensive patients. Acta Clinica Croatica, 54(4), 438–444.PubMed

37.

Côté, I., Farris, K., & Feeny, D. (2003). Is adherence to drug treatment correlated with health-related quality of life? Quality of Life Research, 12(6), 621–633.CrossRefPubMed

38.

Martínez, Y. V., Prado-Aguilar, C. A., Rascón-Pacheco, R. A., & Valdivia-Martínez, J. J. (2008). Quality of life associated with treatment adherence in patients with type 2 diabetes: A cross-sectional study. BMC Health Services Research, 8, 164. https://doi.org/10.1186/1472-6963-8-164.CrossRefPubMedPubMedCentral

39.

Kim, J. H., Lee, W. Y., Hong, Y. P., Ryu, W. S., Lee, K. J., Lee, W. S., & Morisky, D. E. (2014). Psychometric properties of a short self-reported measure of medication adherence among patients with hypertension treated in a busy clinical setting in Korea. Journal of Epidemiology, 24(2), 132–140.CrossRefPubMedPubMedCentral

40.

Al-Qazaz, H. Kh, Hassali, M. A., Shafie, A. A., Sulaiman, S. A., Sundram, S., & Morisky, D. E. (2010). The eight-item Morisky Medication Adherence Scale MMAS: Translation and validation of the Malaysian version. Diabetes Research and Clinical Practice, 90(2), 216–221. https://doi.org/10.1016/j.diabres.2010.08.012.CrossRefPubMedPubMedCentral

41.

Ashur, S. T., Shamsuddin, K., Shah, S. A., Bosseri, S., & Morisky, D. E. (2015). Reliability and known-group validity of the Arabic version of the 8-item Morisky Medication Adherence Scale among type 2 diabetes mellitus patients. Eastern Mediterranean Health Journal, 21(10), 722–728.CrossRefPubMed

42.

Sokol, M. C., McGuigan, K. A., Verbrugge, R. R., & Epstein, R. S. (2005). Impact of medication adherence on hospitalization risk and health care cost. Medical Care, 43(6), 521–530.CrossRefPubMed

43.

Balkrishnan, R., Rajagopalan, R., Camacho, F. T., Huston, S. A., Murray, F. T., & Anderson, R. T. (2003). Predictors of medication adherence and associated health care costs in an older population with type 2 diabetes mellitus: A longitudinal cohort study. Clinical Therapeutics, 25(11), 2958–2971.CrossRefPubMed

44.

Son, S. Y. (2009). A study on health status and health related quality of life by job characteristics in Korean adult women. Korean Journal of Occupational Health Nursing, 18, 33–43.

45.

Daley, D. J., Deane, K. H. O., Gray, R. J., Hill, R., & Myint, P. K. (2015). Qualitative evaluation of adherence therapy in Parkinson’s disease: A multidirectional model. Patient Preference and Adherence, 9, 989–998. https://doi.org/10.2147/PPA.S80158.CrossRefPubMedPubMedCentral

46.

Jaam, M., Ibrahim, M. I. M., Kheir, N., Hadi, M. A., Diab, M. I., & Awaisu, A. (2018). Assessing prevalence of and barriers to medication adherence in patients with uncontrolled diabetes attending primary healthcare clinics in Qatar. Primary Care Diabetes, 12(2), 116–125. https://doi.org/10.1016/j.pcd.2017.11.001.CrossRefPubMed

47.

Williams, G. H. (1998). Assessing patient wellness: New perspectives on quality of life and compliance. American Journal of Hypertension, 11(11), 186S–191S.CrossRefPubMed

48.

Croog, S. H., Levine, S., Testa, M. A., Brown, B., Bulpitt, C. J., Jenkins, C. D., et al. (1986). The effects of antihypertensive therapy on the quality of life. The New England Journal of Medicine, 314(26), 1657–1664. https://doi.org/10.1056/NEJM198606263142602.CrossRefPubMed

49.

Bulpitt, C. J., Connor, M., Schulte, M., & Fletcher, A. E. (2000). Bisoprolol and nifedipine retard in elderly hypertensive patients: Effect on quality of life. Journal of Human Hypertension, 14(3), 205–212.CrossRefPubMed

50.

Fletcher, A. E., Bulpitt, C. J., Chase, D. M., Collins, W. C., Furberg, C. D., Goggin, T. K., et al. (1992). Quality of life with three antihypertensive treatments. Cilazapril, atenolol, nifedipine. Hypertension, 19(6 Pt 1), 499–507.CrossRefPubMed

51.

Vanmolkot, F. H., de Hoon, J. N., van de Ven, L. L., & Van Bortel, L. M. (1999). Impact of antihypertensive treatment on quality of life: Comparison between bisoprolol and bendrofluazide. Journal of Human Hypertension, 13(8), 559–563.CrossRefPubMed

52.

Nunes, M. I. (2001). The relationship between quality of life and adherence to treatment. Current Hypertension Reports, 3(6), 462–465.CrossRefPubMed

Title: Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics: a cross-sectional survey
Publication date: 01-04-2019
Published in: Quality of Life Research / Issue 4/2019
Print ISSN: 0962-9343
Electronic ISSN: 1573-2649
DOI: https://doi.org/10.1007/s11136-018-2060-8

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Association between medication adherence and quality of life of patients with diabetes and hypertension attending primary care clinics: a cross-sectional survey

Abstract

Purpose

Methods

Results

Conclusion

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Purpose

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2019

Measuring subjective wellbeing in patients with heart disease: relationship and comparison between health-related quality of life instruments

Is it possible to determine the level of functional impairment that distinguishes the patients with ADHD from those without ADHD?

Developmental coordination disorder: the impact on the family

Exploring the item sets of the Recovering Quality of Life (ReQoL) measures using factor analysis

Defining the cut-off point of clinically significant postoperative fatigue in three common fatigue scales

Individualized health-related quality of life instrument Measure Yourself Medical Outcome Profile (MYMOP) and its adaptations: a critical appraisal